Kiromic SEC Order Shows Importance Of Self-Reporting
On Dec. 3, the U.S. Securities and Exchange Commission announced[1] that it filed settled charges against Kiromic BioPharma Inc., its former CEO Maurizio Chiriva-Internati and its former Chief Financial Officer Tony Tontat....To view the full article, register now.
Already a subscriber? Click here to view full article